Jefferies Group restated their hold rating on shares of Clorox (NYSE:CLX) in a research report report published on Wednesday. The brokerage currently has a $130.00 price objective on the stock.

Several other brokerages have also issued reports on CLX. Zacks Investment Research lowered shares of Clorox from a hold rating to a sell rating in a research note on Wednesday, October 4th. Morgan Stanley dropped their price objective on shares of Clorox from $138.00 to $128.00 and set an equal weight rating on the stock in a research note on Thursday, November 2nd. Consumer Edge raised shares of Clorox from a neutral rating to an outperform rating in a research note on Friday, November 10th. BMO Capital Markets reaffirmed a buy rating and issued a $150.00 price objective on shares of Clorox in a research note on Thursday, October 5th. Finally, Wells Fargo & Company reaffirmed a hold rating and issued a $130.00 price objective on shares of Clorox in a research note on Wednesday. Two investment analysts have rated the stock with a sell rating, ten have issued a hold rating and three have issued a buy rating to the company’s stock. The stock presently has a consensus rating of Hold and a consensus target price of $129.05.

Shares of Clorox (CLX) traded up $1.46 during midday trading on Wednesday, reaching $146.61. 849,900 shares of the company traded hands, compared to its average volume of 817,212. The company has a market capitalization of $18,900.00, a price-to-earnings ratio of 26.15, a PEG ratio of 3.95 and a beta of 0.43. Clorox has a fifty-two week low of $115.00 and a fifty-two week high of $147.38. The company has a debt-to-equity ratio of 3.02, a quick ratio of 0.77 and a current ratio of 1.10.

Clorox (NYSE:CLX) last issued its earnings results on Wednesday, November 1st. The company reported $1.46 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.41 by $0.05. The business had revenue of $1.50 billion for the quarter, compared to analyst estimates of $1.48 billion. Clorox had a net margin of 11.84% and a return on equity of 161.59%. Clorox’s revenue was up 4.0% on a year-over-year basis. During the same period in the prior year, the firm earned $1.36 earnings per share. equities analysts anticipate that Clorox will post 5.6 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, February 9th. Stockholders of record on Wednesday, January 24th will be issued a $0.84 dividend. The ex-dividend date of this dividend is Tuesday, January 23rd. This represents a $3.36 annualized dividend and a dividend yield of 2.29%. Clorox’s dividend payout ratio is currently 61.65%.

In other news, SVP Michael R. Costello sold 10,574 shares of the stock in a transaction dated Tuesday, November 28th. The shares were sold at an average price of $136.01, for a total value of $1,438,169.74. Following the completion of the sale, the senior vice president now owns 34,867 shares in the company, valued at $4,742,260.67. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, SVP Matthew T. Laszlo sold 20,051 shares of the stock in a transaction dated Wednesday, November 8th. The shares were sold at an average price of $130.46, for a total transaction of $2,615,853.46. Following the completion of the sale, the senior vice president now owns 10,896 shares of the company’s stock, valued at approximately $1,421,492.16. The disclosure for this sale can be found here. Corporate insiders own 1.00% of the company’s stock.

Several hedge funds have recently made changes to their positions in the company. Shell Asset Management Co. increased its holdings in Clorox by 102.5% during the third quarter. Shell Asset Management Co. now owns 119,382 shares of the company’s stock worth $11,465,000 after buying an additional 60,427 shares during the last quarter. Synovus Financial Corp increased its holdings in Clorox by 14.5% during the second quarter. Synovus Financial Corp now owns 8,786 shares of the company’s stock worth $1,173,000 after buying an additional 1,114 shares during the last quarter. OMERS ADMINISTRATION Corp purchased a new stake in Clorox during the second quarter worth about $2,184,000. Ameriprise Financial Inc. increased its holdings in Clorox by 24.6% during the second quarter. Ameriprise Financial Inc. now owns 1,341,272 shares of the company’s stock worth $178,433,000 after buying an additional 265,200 shares during the last quarter. Finally, Northwestern Mutual Wealth Management Co. increased its holdings in Clorox by 3.2% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 44,974 shares of the company’s stock worth $5,992,000 after buying an additional 1,399 shares during the last quarter. Institutional investors own 73.42% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Clorox (CLX) Receives Hold Rating from Jefferies Group” was first published by Daily Political and is owned by of Daily Political. If you are viewing this news story on another domain, it was illegally stolen and reposted in violation of international trademark and copyright legislation. The original version of this news story can be read at https://www.dailypolitical.com/2017/12/14/clorox-clx-receives-hold-rating-from-jefferies-group.html.

Clorox Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Analyst Recommendations for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.